Lipoxin A4

Produced by the metabolism of 15-HETE or 15-HpETE with leukocytes

此产品仅用于科学研究，我们不为任何个人用途提供产品和服务

库存: 现货

可选规格

包装

价格

促销价

数量
25ug

￥3437.00

2750.00

- +
50ug

￥6462.00

5170.00

- +
100ug

￥12087.00

9670.00

- +
250ug

￥26837.00

21470.00

- +

已选 0 种 0 瓶

金额: ￥0.00

首页收藏

货号: ajci21346
CAS: 89663-86-5
别名: 脂氧素 A4; LXA4
分子式: C20H32O5
分子量: 352.5
纯度: >98%
溶解度: DMF: 50 mg/mL; Ethanol: 50 mg/mL; PBS pH 7.2: 1 mg/mL
储存: Store at -80°C, protect form light
库存: 现货

Background

Lipoxin A4 (LXA4) is a trihydroxy fatty acid containing a conjugated tetraene, produced by the metabolism of (±)15-HETE? or 15-HpETE with human leukocytes.[1] LXA4 is equipotent to leukotriene B4 in inducing superoxide generation in human neutrophils at 0.1 μM.2 LXA4 is associated with several other biological functions including leukocyte activation, chemotaxis effects, natural killer cell inhibition, and monocyte migration and adhesion.[2],[3],[4] Analytical and biological comparisons of synthetic LXA4 with endogenously derived LXA4 have confirmed its identity as matching the natural product.[5]

Lipoxin A4 (LXA4)是一种三羟基脂肪酸，含有一个共轭四烯，通过人类白细胞代谢(±)15-HETE或15-HpETE产生[1]。在0.1 μM的浓度下，LXA4与白三烯B4具有相同的诱导人类中性粒细胞产生超氧化物的效果[2]。LXA4与许多其他生物学功能有关，包括白细胞激活、趋化效应、自然杀伤细胞抑制、单核细胞迁移和粘附等[2],[3],[4]。合成LXA4与内源性LXA4的分析和生物学比较已经证实其身份与天然产物相匹配[5]。

Reference:
[1]. Serhan, C.N., Nicolaou, K.C., Webber, S.E., et al. Lipoxin A. Stereochemistry and biosynthesis. J. Biol. Chem. 261(35), 16340-16345 (1986).
[2]. Serhan, C.N., Hamberg, M., and Samuelsson, B. Lipoxins: Novel series of biologically active compounds formed from arachidonic acid in human leukocytes. Proc. Natl. Acad. Sci. U.S.A. 81(17), 5335-5339 (1984).
[3]. Ramstedt, U., Serhan, C.N., Nicolaou, K.C., et al. Lipoxin A-induced inhibition of human natural killer cell cytotoxicity: Studies on stereospecificity of inhibition and mode of action. J. Immunol. 138(1), 266-270 (1987).
[4]. Maddox, J.F., and Serhan, C.N. Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: Selective inactivation by dehydrogenation and reduction. J. Exp. Med. 183(1), 137-146 (1996).
[5]. Serhan, C. . (2007).